RNF213 and multiminicore myopathy: Previous studies showed that in Japan and Korea, the founder variant RNF213 p.R4810K was much more frequent in MMD patients (~80%) than in the general population (~1.0%), significantly increased MMD risk (ORs > 100) [1, 2, 5, 8, 9, 25].